Drugs / Menevit
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00100269 | Dec 2004 → Mar 2006 | disorder of defective peroxisome oxidative status, male infertility | Repromed | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Menevit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00100269 ↗ |
| Modality | Other / unclassified | “novel anti-oxidant preparation (Menevit)” NCT00100269 ↗ |
| Route | Oral | “taken orally once per day” NCT00100269 ↗ |